Literature DB >> 28459537

Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs.

Jesse J McClure1, Elizabeth S Inks1, Cheng Zhang2, Yuri K Peterson1, Jiaying Li1, Kalyan Chundru1, Bradley Lee1,3, Ashley Buchanan3, Shiqin Miao4, C James Chou1.   

Abstract

The acetylation status of lysine residues on histone proteins has long been attributed to a balance struck between the catalytic activity of histone acetyl transferases and histone deacetylases (HDAC). HDACs were identified as the sole removers of acetyl post-translational modifications (PTM) of histone lysine residues. Studies into the biological role of HDACs have also elucidated their role as removers of acetyl PTMs from lysine residues of nonhistone proteins. These findings, coupled with high-resolution mass spectrometry studies that revealed the presence of acyl-group PTMs on lysine residues of nonhistone proteins, brought forth the possibility of HDACs acting as removers of both acyl- and acetyl-based PTMs. We posited that HDACs fulfill this dual role and sought to investigate their specificity. Utilizing a fluorescence-based assay and biologically relevant acyl-substrates, the selectivities of zinc-dependent HDACs toward these acyl-based PTMs were identified. These findings were further validated using cellular models and molecular biology techniques. As a proof of principal, an HDAC3 selective inhibitor was designed using HDAC3's substrate preference. This resulting inhibitor demonstrates nanomolar activity and >30 fold selectivity toward HDAC3 compared to the other class I HDACs. This inhibitor is capable of increasing p65 acetylation, attenuating NF-κB activation, and thereby preventing downstream nitric oxide signaling. Additionally, this selective HDAC3 inhibition allows for control of HMGB-1 secretion from activated macrophages without altering the acetylation status of histones or tubulin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28459537      PMCID: PMC5567816          DOI: 10.1021/acschembio.7b00321

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  51 in total

1.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

2.  A novel class of small molecule inhibitors of HDAC6.

Authors:  Elizabeth S Inks; Benjamin J Josey; Sean R Jesinkey; C James Chou
Journal:  ACS Chem Biol       Date:  2011-11-11       Impact factor: 5.100

3.  Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages.

Authors:  Xuefen Chen; Iros Barozzi; Alberto Termanini; Elena Prosperini; Antonio Recchiuti; Jesmond Dalli; Flore Mietton; Gianluca Matteoli; Scott Hiebert; Gioacchino Natoli
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

4.  Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

Authors:  Minjia Tan; Hao Luo; Sangkyu Lee; Fulai Jin; Jeong Soo Yang; Emilie Montellier; Thierry Buchou; Zhongyi Cheng; Sophie Rousseaux; Nisha Rajagopal; Zhike Lu; Zhen Ye; Qin Zhu; Joanna Wysocka; Yang Ye; Saadi Khochbin; Bing Ren; Yingming Zhao
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

5.  Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro.

Authors:  Andreas S Madsen; Christian A Olsen
Journal:  Angew Chem Int Ed Engl       Date:  2012-08-13       Impact factor: 15.336

6.  A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

Authors:  V M Richon; S Emiliani; E Verdin; Y Webb; R Breslow; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.

Authors:  Pierre Tessier; David V Smil; Amal Wahhab; Silvana Leit; Jubrail Rahil; Zuomei Li; Robert Déziel; Jeffrey M Besterman
Journal:  Bioorg Med Chem Lett       Date:  2009-08-07       Impact factor: 2.823

8.  Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.

Authors:  Jintang Du; Yeyun Zhou; Xiaoyang Su; Jiu Jiu Yu; Saba Khan; Hong Jiang; Jungwoo Kim; Jimin Woo; Jun Huyn Kim; Brian Hyun Choi; Bin He; Wei Chen; Sheng Zhang; Richard A Cerione; Johan Auwerx; Quan Hao; Hening Lin
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

9.  Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK.

Authors:  Yu-yi Lin; Samara Kiihl; Yasir Suhail; Shang-Yun Liu; Yi-hsuan Chou; Zheng Kuang; Jin-ying Lu; Chin Ni Khor; Chi-Long Lin; Joel S Bader; Rafael Irizarry; Jef D Boeke
Journal:  Nature       Date:  2012-02-08       Impact factor: 49.962

10.  Quantitative analysis of histone modifications: formaldehyde is a source of pathological n(6)-formyllysine that is refractory to histone deacetylases.

Authors:  Bahar Edrissi; Koli Taghizadeh; Peter C Dedon
Journal:  PLoS Genet       Date:  2013-02-28       Impact factor: 5.917

View more
  9 in total

1.  Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status.

Authors:  Xiaoyang Li; Yuri K Peterson; Elizabeth S Inks; Richard A Himes; Jiaying Li; Yingjie Zhang; Xiujie Kong; C James Chou
Journal:  J Med Chem       Date:  2018-03-09       Impact factor: 7.446

Review 2.  Modulation of cellular processes by histone and non-histone protein acetylation.

Authors:  Maria Shvedunova; Asifa Akhtar
Journal:  Nat Rev Mol Cell Biol       Date:  2022-01-18       Impact factor: 113.915

Review 3.  The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors.

Authors:  Fangyuan Cao; Martijn R H Zwinderman; Frank J Dekker
Journal:  Molecules       Date:  2018-03-02       Impact factor: 4.411

4.  Lysine benzoylation is a histone mark regulated by SIRT2.

Authors:  He Huang; Di Zhang; Yi Wang; Mathew Perez-Neut; Zhen Han; Y George Zheng; Quan Hao; Yingming Zhao
Journal:  Nat Commun       Date:  2018-08-28       Impact factor: 14.919

5.  SAHA is neuroprotective in in vitro and in situ models of retinitis pigmentosa.

Authors:  Nathan R Perron; Cécile Nasarre; Mausumi Bandyopadhyay; Craig C Beeson; Baerbel Rohrer
Journal:  Mol Vis       Date:  2021-04-02       Impact factor: 2.367

6.  Hydroxamic acid-modified peptide microarrays for profiling isozyme-selective interactions and inhibition of histone deacetylases.

Authors:  Carlos Moreno-Yruela; Michael Bæk; Adela-Eugenie Vrsanova; Clemens Schulte; Hans M Maric; Christian A Olsen
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

Review 7.  Targeting HDAC Complexes in Asthma and COPD.

Authors:  Martijn R H Zwinderman; Sander de Weerd; Frank J Dekker
Journal:  Epigenomes       Date:  2019-09-07

Review 8.  Regulation of Protein Post-Translational Modifications on Metabolism of Actinomycetes.

Authors:  Chen-Fan Sun; Yong-Quan Li; Xu-Ming Mao
Journal:  Biomolecules       Date:  2020-07-29

9.  Systemic exosomal miR-193b-3p delivery attenuates neuroinflammation in early brain injury after subarachnoid hemorrhage in mice.

Authors:  Niansheng Lai; Degang Wu; Tianyu Liang; Pengjie Pan; Guiqiang Yuan; Xiang Li; Haiying Li; Haitao Shen; Zhong Wang; Gang Chen
Journal:  J Neuroinflammation       Date:  2020-02-25       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.